130 related articles for article (PubMed ID: 9829450)
1. A cost-of-illness study of Lyme disease in the United States.
Maes E; Lecomte P; Ray N
Clin Ther; 1998; 20(5):993-1008; discussion 992. PubMed ID: 9829450
[TBL] [Abstract][Full Text] [Related]
2. The economic burden of Lyme disease and the cost-effectiveness of Lyme disease interventions: A scoping review.
Mac S; da Silva SR; Sander B
PLoS One; 2019; 14(1):e0210280. PubMed ID: 30608986
[TBL] [Abstract][Full Text] [Related]
3. Lyme disease--what is the cost for Scotland?
Joss AW; Davidson MM; Ho-Yen DO; Ludbrook A
Public Health; 2003 Jul; 117(4):264-73. PubMed ID: 12966749
[TBL] [Abstract][Full Text] [Related]
4. Economic impact of Lyme disease.
Zhang X; Meltzer MI; Peña CA; Hopkins AB; Wroth L; Fix AD
Emerg Infect Dis; 2006 Apr; 12(4):653-60. PubMed ID: 16704815
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology and cost of Lyme disease-related hospitalizations among patients with employer-sponsored health insurance-United States, 2005-2014.
Schwartz AM; Shankar MB; Kugeler KJ; Max RJ; Hinckley AF; Meltzer MI; Nelson CA
Zoonoses Public Health; 2020 Jun; 67(4):407-415. PubMed ID: 32462811
[TBL] [Abstract][Full Text] [Related]
6. Estimating direct healthcare costs attributable to laboratory-confirmed Lyme disease in Ontario, Canada: A population-based matched cohort study using health administrative data.
Shing E; Wang J; Khoo E; Evans GA; Moore S; Nelder MP; Patel SN; Russell C; Sider D; Sander B
Zoonoses Public Health; 2019 Jun; 66(4):428-435. PubMed ID: 30665259
[TBL] [Abstract][Full Text] [Related]
7. The cost of Lyme borreliosis.
van den Wijngaard CC; Hofhuis A; Wong A; Harms MG; de Wit GA; Lugnér AK; Suijkerbuijk AWM; Mangen MJ; van Pelt W
Eur J Public Health; 2017 Jun; 27(3):538-547. PubMed ID: 28444236
[TBL] [Abstract][Full Text] [Related]
8. The cost-effectiveness of vaccination against Lyme disease.
Shadick NA; Liang MH; Phillips CB; Fossel K; Kuntz KM
Arch Intern Med; 2001 Feb; 161(4):554-61. PubMed ID: 11252114
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness analysis of the Lyme disease vaccine.
Hsia EC; Chung JB; Schwartz JS; Albert DA
Arthritis Rheum; 2002 Jun; 46(6):1651-60. PubMed ID: 12115198
[TBL] [Abstract][Full Text] [Related]
10. Increasing Burden of Lyme Carditis in United States Children's Hospitals.
Beach CM; Hart SA; Nowalk A; Feingold B; Kurland K; Arora G
Pediatr Cardiol; 2020 Feb; 41(2):258-264. PubMed ID: 31728570
[TBL] [Abstract][Full Text] [Related]
11. [Direct and indirect diabetes costs in the world].
Logminiene Z; Norkus A; Valius L
Medicina (Kaunas); 2004; 40(1):16-26. PubMed ID: 14764977
[TBL] [Abstract][Full Text] [Related]
12. Health care costs, utilization and patterns of care following Lyme disease.
Adrion ER; Aucott J; Lemke KW; Weiner JP
PLoS One; 2015; 10(2):e0116767. PubMed ID: 25650808
[TBL] [Abstract][Full Text] [Related]
13. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
14. Economic Burden of Psoriasis in the United States: A Systematic Review.
Brezinski EA; Dhillon JS; Armstrong AW
JAMA Dermatol; 2015 Jun; 151(6):651-8. PubMed ID: 25565304
[TBL] [Abstract][Full Text] [Related]
15. Economic costs of diabetes in the U.S. In 2007.
American Diabetes Association
Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
[TBL] [Abstract][Full Text] [Related]
16. The Economic Burden of Asthma in the United States, 2008-2013.
Nurmagambetov T; Kuwahara R; Garbe P
Ann Am Thorac Soc; 2018 Mar; 15(3):348-356. PubMed ID: 29323930
[TBL] [Abstract][Full Text] [Related]
17. Clinical manifestations of reported Lyme disease cases in Ontario, Canada: 2005-2014.
Johnson KO; Nelder MP; Russell C; Li Y; Badiani T; Sander B; Sider D; Patel SN
PLoS One; 2018; 13(6):e0198509. PubMed ID: 29856831
[TBL] [Abstract][Full Text] [Related]
18. Estimating the population health burden of Lyme disease in Ontario, Canada: a microsimulation modelling approach.
Mac S; Evans GA; Patel SN; Pullenayegum EM; Sander B
CMAJ Open; 2021; 9(4):E1005-E1012. PubMed ID: 34785530
[TBL] [Abstract][Full Text] [Related]
19. Cost-benefit analysis of first-generation antihistamines in the treatment of allergic rhinitis.
Sullivan PW; Follin SL; Nichol MB
Pharmacoeconomics; 2004; 22(14):929-42. PubMed ID: 15362929
[TBL] [Abstract][Full Text] [Related]
20. The burden of skin diseases: 2004 a joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology.
Bickers DR; Lim HW; Margolis D; Weinstock MA; Goodman C; Faulkner E; Gould C; Gemmen E; Dall T; ;
J Am Acad Dermatol; 2006 Sep; 55(3):490-500. PubMed ID: 16908356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
